Revvity Inc. (RVTY) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.025x

Based on the latest financial reports, Revvity Inc. (RVTY) has a cash flow conversion efficiency ratio of 0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($183.28 Million) by net assets ($7.25 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Revvity Inc. - Cash Flow Conversion Efficiency Trend (1989–2025)

This chart illustrates how Revvity Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read RVTY current and long-term liabilities for a breakdown of total debt and financial obligations.

Revvity Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Revvity Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Viper Energy Ut
NASDAQ:VNOM
0.039x
Macrotech Developers Limited
NSE:LODHA
0.062x
Waaree Energies Limited
NSE:WAAREEENER
0.088x
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
0.014x
Old Republic International Corp
NYSE:ORI
0.095x
IAMGold Corporation
TO:IMG
0.078x
Enel Américas S.A
SN:ENELAM
0.039x
Bangkok Bank PCL
BK:BBL
0.014x

Annual Cash Flow Conversion Efficiency for Revvity Inc. (1989–2025)

The table below shows the annual cash flow conversion efficiency of Revvity Inc. from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Revvity Inc..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $7.25 Billion $581.78 Million 0.080x -2.09%
2024-12-31 $7.67 Billion $628.30 Million 0.082x +606.86%
2023-12-31 $7.87 Billion $91.27 Million 0.012x -87.41%
2022-12-31 $7.38 Billion $679.81 Million 0.092x -53.39%
2021-12-31 $7.14 Billion $1.41 Billion 0.198x -17.29%
2020-12-31 $3.74 Billion $892.18 Million 0.239x +84.90%
2019-12-31 $2.81 Billion $363.47 Million 0.129x +7.35%
2018-12-31 $2.58 Billion $311.04 Million 0.120x +4.42%
2017-12-31 $2.50 Billion $288.45 Million 0.115x -29.22%
2016-12-31 $2.15 Billion $350.62 Million 0.163x +19.68%
2015-12-31 $2.11 Billion $287.10 Million 0.136x -1.35%
2014-12-31 $2.04 Billion $281.60 Million 0.138x +73.42%
2013-12-31 $1.99 Billion $158.59 Million 0.080x +1.36%
2012-12-31 $1.94 Billion $152.17 Million 0.078x -35.74%
2011-12-31 $1.84 Billion $224.87 Million 0.122x +43.09%
2010-12-31 $1.93 Billion $164.25 Million 0.085x -6.56%
2009-12-31 $1.63 Billion $148.72 Million 0.091x -34.29%
2008-12-31 $1.57 Billion $217.84 Million 0.139x +6.70%
2007-12-31 $1.58 Billion $205.13 Million 0.130x +61.21%
2006-12-31 $1.58 Billion $127.44 Million 0.081x -35.93%
2005-12-31 $1.65 Billion $208.09 Million 0.126x -8.30%
2004-12-31 $1.46 Billion $200.76 Million 0.137x +10.76%
2003-12-31 $1.35 Billion $167.47 Million 0.124x +53.17%
2002-12-31 $1.25 Billion $101.50 Million 0.081x -10.37%
2001-12-31 $1.36 Billion $123.30 Million 0.090x -54.75%
2000-12-31 $728.39 Million $145.55 Million 0.200x -4.96%
1999-12-31 $550.80 Million $115.80 Million 0.210x +20.74%
1998-12-31 $399.70 Million $69.60 Million 0.174x +64.27%
1997-12-31 $328.30 Million $34.80 Million 0.106x -51.74%
1996-12-31 $365.10 Million $80.20 Million 0.220x -46.34%
1995-12-31 $366.90 Million $150.20 Million 0.409x +90.13%
1994-12-31 $445.40 Million $95.90 Million 0.215x -8.29%
1993-12-31 $477.50 Million $112.10 Million 0.235x -13.00%
1992-12-31 $473.60 Million $127.80 Million 0.270x +8.74%
1991-12-31 $420.70 Million $104.40 Million 0.248x -29.01%
1990-12-31 $369.60 Million $129.20 Million 0.350x +132.82%
1989-12-31 $349.00 Million $52.40 Million 0.150x --

About Revvity Inc.

NYSE:RVTY USA Diagnostics & Research
Market Cap
$9.69 Billion
Market Cap Rank
#2285 Global
#816 in USA
Share Price
$86.68
Change (1 day)
+0.07%
52-Week Range
$82.26 - $117.75
All Time High
$199.71
About

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more